Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeProfit After TaxResearch & DevelopmentSelling, General & AdministrativeTax ProvisionsTax Rate
Others
Ratios

Edesa Biotech (EDSA) Shares Outstanding (Weighted Average) (2016 - 2022)

Edesa Biotech's Shares Outstanding (Weighted Average) history spans 9 years, with the latest figure at $12.1 million for Q3 2021.

  • For Q3 2021, Shares Outstanding (Weighted Average) rose 40.32% year-over-year to $12.1 million; the TTM value through Sep 2021 reached $12.1 million, up 40.32%, while the annual FY2021 figure was $12.1 million, 40.32% up from the prior year.
  • Shares Outstanding (Weighted Average) for Q3 2021 was $12.1 million at Edesa Biotech, down from $13.3 million in the prior quarter.
  • Across five years, Shares Outstanding (Weighted Average) topped out at $13.3 million in Q2 2021 and bottomed at $1.4 million in Q1 2017.
  • The 5-year median for Shares Outstanding (Weighted Average) is $3.4 million (2018), against an average of $5.7 million.
  • The largest annual shift saw Shares Outstanding (Weighted Average) plummeted 85.17% in 2017 before it soared 150.59% in 2020.
  • A 5-year view of Shares Outstanding (Weighted Average) shows it stood at $1.5 million in 2017, then soared by 115.58% to $3.2 million in 2018, then soared by 131.63% to $7.5 million in 2019, then skyrocketed by 36.96% to $10.3 million in 2020, then increased by 17.51% to $12.1 million in 2021.
  • Per Business Quant, the three most recent readings for EDSA's Shares Outstanding (Weighted Average) are $12.1 million (Q3 2021), $13.3 million (Q2 2021), and $11.6 million (Q1 2021).